Intellia (NTLA) | Stock Overview & Key Data
Intellia Performance Comparison
Stock Range
Today's Range
Low: $8.95
High: $9.94
on June 20, 2025
52 Week Range
Low: $5.90
High: $28.18
on April 7, 2025
on July 17, 2024
All-Time High: $202.73 on June 28, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.2B
EPS
-4.69
P/E Ratio (TTM)
-2.05
Forward P/E
-1.96
P/B Ratio
1.59
PEG Ratio
-1.96
Div. Yield
N/A
ROE
-56.95%
Beta
2.315
Debt to Equity
14.34
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-772.17%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-30.62%
Return on Equity (TTM)
-56.95%
EBITDA
$-501.9M
Net Income (TTM)
$-480.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.52
Quarterly Revenue Growth (YoY)
104.80%
Quarterly Earnings Growth (YoY)
104.76%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Intellia NTLA | 1.16B Small-cap | 1.85% | -4.27% | 36.18% | -4.68% | -10.07% | -51.44% | -80.48% | -45.81% |
| Vertex VRTX | 100.19B Large-cap | 1.83% | -13.31% | -8.70% | -17.92% | -2.05% | -17.41% | 41.10% | 47.23% |
| Regeneron REGN | 62.88B Large-cap | 5.69% | 9.65% | -1.07% | -14.59% | -16.36% | -50.12% | 0.33% | -0.74% |
| Harmony Biosciences HRMY | 2.10B Mid-cap | 2.14% | 5.79% | 8.09% | 7.90% | 7.06% | 2.56% | -21.66% | 5.94% |
| Cg Oncology CGON | 1.99B Small-cap | 0.08% | -3.42% | -0.92% | -6.71% | -10.32% | -29.82% | -25.83% | -25.83% |
| Celcuity CELC | 2.19B Mid-cap | -2.91% | 272.08% | 375.28% | 283.12% | 283.70% | 190.37% | 407.86% | 776.17% |
Ownership & Short Interest
Insider Ownership
4.80%
Institutional Ownership
90.55%
Shares Short
29M
Short Ratio
5.98
Short % of Shares Outstanding
31.72%
Average 10-Day Volume
5M
Average 90-Day Volume
5M
Intellia Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Intellia would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is NTLA's 52-week high and low?
- In the last 52 weeks, Intellia reached a high of $28.18 (on July 17, 2024) and a low of $5.90 (on April 7, 2025).
- What is the market cap and P/E ratio for NTLA?
- Curious about Intellia's size and valuation? Its market capitalization stands at 1.16B. When it comes to valuation, the P/E ratio (trailing twelve months) is -2.05, and the forward P/E (looking ahead) is -1.96.
- Does NTLA pay dividends? If so, what's the yield?
- As for dividends, Intellia isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Intellia's main competitors or similar companies to consider before investing?
When looking at Intellia, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Vertex
VRTX100.19B Healthcare Biotechnology -17.41% 41.10% Regeneron
REGN62.88B Healthcare Biotechnology -50.12% 0.33% Harmony Biosciences
HRMY2.10B Healthcare Biotechnology 2.56% -21.66% Cg Oncology
CGON1.99B Healthcare Biotechnology -29.82% -25.83% Celcuity
CELC2.19B Healthcare Biotechnology 190.37% 407.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Intellia Therapeutics Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Intellia's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -56.95%, the Debt to Equity ratio from the most recent quarter is 14.34, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for NTLA?
- Looking at Intellia's growth, its revenue over the trailing twelve months (TTM) was $53M. Compared to the same quarter last year (YoY), quarterly revenue grew by 104.80%, and quarterly earnings saw a YoY growth of 104.76%.
- How much of NTLA stock is held by insiders and institutions?
- Wondering who owns Intellia stock? Company insiders (like executives and directors) hold about 4.80% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 90.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.